患有并发性克隆性血细胞和髓状细胞疾病的患者的管理:单一中心描述病例系列
Michael J Hochman1,2, Gloria F Gerber2, Philip H Imus1
1Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States.
Leukemia research reports
|August 7, 2024
概括
同时发生的克隆性血细胞和髓状细胞疾病 (CPCMD) 带来了挑战. 建议优先考虑基因病变或末端器官并发症的克隆导向疗法,逐步同时治疗是安全的选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 克隆性血细胞和髓状细胞疾病随着年龄的增长而增加.
- 同时发生的克隆性血细胞和髓状细胞疾病 (CPCMD) 带来了重大的临床和治疗挑战.
研究的目的:
- 审查CPCMD患者的临床主题和治疗策略.
- 为了确定双克隆性血液学疾病的最佳治疗方法.
主要方法:
- 一个单一机构的18名患有CPCMD的患者队列的回顾性分析.
- 临床相关主题和治疗数据的抽象.
主要成果:
- 在18名患者中,有12名患者接受了克隆导向疗法.
- 三名患者接受治疗,同时准两种克隆.
- 治疗优先级集中在具有可向遗传病变或末端器官并发症的克隆.
结论:
- 治疗CPCMD应优先考虑具有特定遗传标记或导致器官损伤的克隆.
- 同时对两种克隆进行治疗是可行的,并且在逐步进行时是安全的.
- 对双克隆性血液学过程的进一步研究是必不可少的.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
4.2K
相关概念视频
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Leukocytes
923
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
923
